Poly Medicure

2,258.60
-26.20
(-1.15%)
Market Cap
23,150.90 Cr
EPS
26.92
PE Ratio
68.44
Dividend Yield
0.15 %
Industry
Healthcare
52 Week High
3,357.80
52 Week Low
1,585.60
PB Ratio
8.38
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
SELL
Analysts have suggested that investors can sell this stock
Buy
Buy+25.00 %
+25.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+75.00 %
+75.00 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,258.60
#1 23,150.90
#7 68.44
#1 1,434.50
#4 24.59
#1 258
#4 34.21
38.49
383.75
2,052.00
76.78
195.30
19.23
18
-44.16
45.06
376.55
2,045.20
68.74
307.90
-0.45
43
-0.97
47.36
603.45
997.50
58.78
173.30
40.00
15
-34.92
45.16
486.40
585.00
32.21
59.30
30.58
16
6.25
52.35
270.95
433.40
21.62
132.70
#1 61.83
13
-
59.60
163.25
292.30
18.14
65.60
-16.22
4
-
74.40
255.52
250.50
296.76
122.10
19.24
1
159.52
59.08
88.65
164.20
#1 15.97
122.60
16.98
9
45.83
47.15
150.80
151.30
18.92
101.10
0.60
2
#1 841.20
64.63
Forecast
Actual
Growth Rate
Revenue Growth
24.59 %
Net Income Growth
44.06 %
Cash Flow Change
39.27 %
ROE
21.68 %
ROCE
22.93 %
EBITDA Margin (Avg.)
11.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
137
155
159
180
166
179
185
178
175
203
209
221
223
237
238
266
254
284
300
316
335
352
357
393
402
447
448
467
Expenses
103
116
125
139
125
132
135
131
125
143
146
159
157
173
179
202
202
210
214
224
234
253
249
282
281
305
310
321
EBITDA
35
39
35
41
41
47
50
47
50
60
63
63
66
64
59
64
51
74
86
92
101
99
108
112
121
142
138
146
Operating Profit %
23 %
23 %
20 %
20 %
23 %
24 %
25 %
23 %
27 %
28 %
28 %
25 %
26 %
23 %
22 %
22 %
19 %
24 %
25 %
27 %
27 %
25 %
27 %
26 %
27 %
27 %
27 %
27 %
Depreciation
9
9
10
10
10
10
11
10
11
11
13
13
13
14
14
14
14
14
14
15
16
16
16
16
20
21
22
21
Interest
4
7
-1
2
3
2
5
8
3
3
5
-2
3
0
-1
2
1
0
5
2
3
2
4
3
3
3
3
2
Profit Before Tax
22
23
26
30
28
36
34
29
36
46
46
52
50
50
46
49
36
59
67
75
83
81
88
93
99
118
113
123
Tax
9
9
10
8
8
7
9
6
10
11
11
13
13
12
11
13
9
16
17
16
20
19
23
24
24
31
28
31
Net Profit
13
15
16
22
20
28
25
23
27
35
35
39
38
38
35
36
27
44
50
59
63
62
65
68
74
87
85
92
EPS in ₹
1.50
1.65
1.82
2.44
2.24
3.22
2.83
2.57
3.03
3.97
4.00
4.26
3.92
3.99
3.60
3.77
2.81
4.53
5.21
6.13
6.54
6.48
6.78
7.12
7.71
9.01
8.48
8.92

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
364
387
457
565
654
767
1,224
1,377
1,577
1,859
Fixed Assets
166
182
207
265
306
363
426
488
635
867
Current Assets
160
171
205
255
302
318
704
783
807
842
Capital Work in Progress
10
14
20
18
19
25
21
43
78
76
Investments
0
0
3
17
8
25
354
346
132
167
Other Assets
189
191
227
264
321
354
422
499
732
749
Total Liabilities
364
387
457
565
654
767
1,224
1,377
1,577
1,859
Current Liabilities
113
109
114
123
154
193
171
227
293
351
Non Current Liabilities
55
50
72
104
119
139
87
63
42
37
Total Equity
196
229
272
338
381
435
966
1,088
1,242
1,470
Reserve & Surplus
174
207
227
294
337
391
918
1,040
1,194
1,422
Share Capital
22
22
44
44
44
44
48
48
48
48

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-2
1
0
3
1
1
0
3
-1
5
Investing Activities
-59
-31
-56
-88
-101
-107
-436
-85
-179
-241
Operating Activities
63
63
56
75
107
128
119
124
191
266
Financing Activities
-6
-31
-0
16
-5
-21
317
-35
-13
-20

Share Holding

% Holding
Feb 2021
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
44.88 %
44.88 %
44.77 %
44.77 %
44.76 %
44.66 %
53.34 %
53.33 %
53.33 %
53.31 %
53.31 %
53.16 %
53.16 %
53.15 %
66.03 %
62.56 %
62.56 %
62.44 %
62.44 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.49 %
0.00 %
12.38 %
9.91 %
11.10 %
11.87 %
12.33 %
11.46 %
DIIs
1.83 %
1.92 %
2.68 %
2.73 %
2.86 %
3.18 %
3.10 %
3.20 %
3.38 %
3.68 %
4.25 %
5.15 %
5.28 %
7.22 %
9.35 %
12.48 %
12.33 %
11.66 %
11.96 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.24 %
15.11 %
14.24 %
13.69 %
13.24 %
12.32 %
11.93 %
11.20 %
11.18 %
11.12 %
11.10 %
11.35 %
11.38 %
11.34 %
11.37 %
10.70 %
10.14 %
10.55 %
11.08 %
Others
37.06 %
38.10 %
38.30 %
38.81 %
39.14 %
39.84 %
31.63 %
32.27 %
32.11 %
31.90 %
31.34 %
15.85 %
30.17 %
15.92 %
3.36 %
3.16 %
3.10 %
3.03 %
3.07 %
No of Share Holders
0
19,187
21,531
35,922
33,678
35,166
33,831
33,296
34,239
35,393
36,141
34,649
36,053
36,712
36,852
40,516
38,352
60,686
65,583

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.5 2 2 2 2.5 2.5 3 3 0.00
Dividend Yield (%) 0.00 1 0.91 0.86 0.24 0.26 0.27 0.19 0.13 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
06 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 May 2025 2,588.50 2,591.10
03 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2025 2,442.30 2,428.85
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 2,452.50 2,515.05
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 2,502.15 2,317.00
20 Sept 2024 DIVIDEND Dividend
₹ 3.00 /share
19 Sept 2024 1,653.80 2,465.30
22 Sept 2023 DIVIDEND Dividend
₹ 3.00 /share
21 Sept 2023 978.85 1,411.50
19 Sept 2022 DIVIDEND Dividend
₹ 2.50 /share
16 Sept 2022 717.35 929.70
17 Sept 2021 DIVIDEND Dividend
₹ 2.50 /share
16 Sept 2021 1,136.45 956.25
28 Mar 2017 BONUS Bonus
1:1
24 Mar 2017 0.00 0.00

Announcements

Statement Of Deviation & Variation - 31St March 2025May 15, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 06, 2025
Re-Appointment Of Internal Auditors Appointment Of Secretarial AuditorMay 06, 2025
Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31.03.2025May 06, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations 2015 May 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 03, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 06Th May 2025.Apr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Closure of Trading WindowMar 31, 2025
Intimation Of Receiving The Medical Device Regulation (MDR) Certification In Europe For 54 ProductsMar 11, 2025
Statement Of Deviation(S) Or Variation(S) For The Quarter Ended 31St December 2024.Feb 13, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 13, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 05, 2025
Integrated Filing (Financial)Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 03, 2025
Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December 2024Feb 03, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 03Rd February 2025Feb 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 03Rd February 2025Jan 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Announcement under Regulation 30 (LODR)-Joint VentureJan 10, 2025
Closure of Trading WindowDec 31, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 02, 2024
Statement Of Deviation(S) Or Variation(S), If Any, Of Utilization Of Proceeds Received From Qualified Institutions Placement (QIP) Under Regulation 32 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015.Nov 13, 2024
Monitoring Agency Report For The Quarter Ended 30Th September, 2024 - QIP Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015Nov 13, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 29, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 28, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementOct 28, 2024
Financial Results For The Quarter And Half Year Ended On 30Th September, 2024.Oct 28, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015Oct 28, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2024
Board Meeting Intimation for Board Meeting Intimation Scheduled To Be Held On 28Th October, 2024.Oct 19, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024

Technical Indicators

RSI(14)
Neutral
39.97
ATR(14)
Less Volatile
94.05
STOCH(9,6)
Neutral
25.11
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-29.37
ADX(14)
Weak Trend
17.10
UO(9)
Bearish
40.40
ROC(12)
Downtrend But Slowing Down
-2.86
WillR(14)
Oversold
-84.55

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth
0
0.00%
-1.31%
0.00%
Apr 2025
SBI Healthcare Opportunities Fund Direct Plan-Growth
540000
3.79%
0.43%
0.47%
Apr 2025
Quant Small Cap Fund Direct Plan-Growth
3143260
3.09%
0.25%
0.37%
Apr 2025
Invesco India ESG Integration Strategy Fund Direct - Growth
44065
2.43%
0.24%
0.37%
Apr 2025
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth
1682
1.79%
0.24%
0.22%
Apr 2025
Invesco India ELSS Tax Saver Fund Direct-Growth
249456
2.36%
0.24%
0.31%
Apr 2025
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
9354
1.79%
0.23%
0.21%
Apr 2025
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
18414
1.48%
-0.19%
-0.28%
Apr 2025
Invesco India Manufacturing Fund Direct-Growth
50022
1.67%
0.17%
0.20%
Apr 2025
Invesco India Multicap Fund Direct-Growth
246785
1.68%
0.16%
0.19%
Apr 2025
Bank of India Small Cap Fund Direct-Growth
96500
1.52%
0.14%
0.11%
Apr 2025
Bank of India ELSS Tax Saver Direct-Growth
59200
1.15%
0.14%
0.13%
Apr 2025
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0
0.00%
-0.13%
-0.11%
Apr 2025
UTI Flexi Cap Fund Direct-Growth
1452175
1.48%
0.13%
0.19%
Apr 2025
WhiteOak Capital ESG Best-In-Class Strategy Fund Direct-Growth
2677
1.11%
0.10%
0.17%
Apr 2025
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth
6961
0.87%
0.09%
0.15%
Apr 2025
UTI Healthcare Fund Direct-Growth
28000
0.69%
0.09%
0.03%
Apr 2025
WhiteOak Capital Flexi Cap Fund Direct - Growth
220830
1.21%
0.09%
0.09%
Apr 2025
WhiteOak Capital ELSS Tax Saver Fund Direct - Growth
16495
1.18%
0.09%
0.05%
Apr 2025
Quant Active Fund Direct-Growth
264798
0.71%
0.09%
0.16%
Apr 2025
Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth
32000
0.75%
0.08%
0.08%
Apr 2025
Bandhan BSE Healthcare Index Fund Direct-Growth
548
0.78%
0.08%
0.10%
Apr 2025
SBI Nifty Smallcap 250 Index Fund Direct - Growth
27962
0.57%
0.07%
0.07%
Apr 2025
Axis Nifty500 Momentum 50 Index Fund Direct-Growth
1365
0.60%
0.07%
0.09%
Apr 2025
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
9234
0.57%
0.07%
0.06%
Apr 2025

About Poly Medicure

Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and Italy, with seven in India, one in China through a wholly-owned subsidiary, one in Egypt through an associate, and one in Italy through a step-down subsidiary. The company exports to over 110 countries through a network of more than 220 distributors. Poly Medicure's facilities are accredited with international quality certifications, including ISO 9001:2015 and EN ISO 13485:2016. The company has an R&D center in Faridabad, Haryana, approved by DSIR, focusing on developing new products and improving existing processes. Poly Medicure holds over 375 patents for its products in various therapeutic areas.
Chairperson NameDevendra Raj Mehta